Menu Close

Aesthetic injectable companies. Procter & Gamble names Jon Moeller Chairman of the Board

Biorevitalization

THE WHAT? Procter & Gamble has named Jon R Moeller as Chairman of the Board. Moeller assumes the position in addition to his role as President and CEO of the company. The Board of Directors has also reappointed Joseph Jimenez as Lead Director.

Meso Therapy

THE DETAILS “I want to recognize and thank David for his leadership of P&G over the last seven years as well as for his 40-plus years of service to the company,” said Mr. Moeller. “We have much to thank him for. Among other things, David committed P&G to achieve balanced top and bottom-line growth, completed the restructuring of our portfolio, and led our most important organization change in decades. We are well-positioned to continue to serve consumers around the world with noticeably superior offerings that improve their lives.”

THE WHY? The announcement follows the retirement of current Executive Chairman, David Taylor. Moeller was named as his successor in 2021, after two decades on the US FMCG giant’s leadership as COO and CFO.

Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.

Key aspects of aesthetic injectable companies include:

  • Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.

  • Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.

  • Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.

  • Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.

  • Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.

  Aesthetic injectable companies. AkzoNobel: our Russian arm will fold by May